Medical Communication (India) Private Limited
Publishes and sells medical books, periodicals, and journals since 1995.
1995 | Mumbai, Maharashtra (India) | Active
Medical Communication (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 74.65%
- Profit Growth 20.59%
- Ebitda 87.85%
- Net Worth -152.84%
- Total Assets 0.80%
About Medical Communication (India)
Medical Communication (India) Private Limited (MCIPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 December 1995 and has a history of 29 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kiran Rebello and Shreeya Jayaraman serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U22210MH1995PTC095240
- Company No.
095240
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 1995
- Date of AGM
01 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Media and Publishing
Who are the key members and board of directors at Medical Communication (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Rebello  | Director | 01-Apr-1997 | Current |
| Shreeya Jayaraman | Director | 10-Nov-2021 | Current |
Financial Performance of Medical Communication (India).
Medical Communication (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 74.65% increase. The company also saw a substantial improvement in profitability, with a 20.59% increase in profit. The company's net worth observed a substantial decline by a decrease of 152.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medical Communication (India)?
In 2022, Medical Communication (India) had a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medical Communication (India)?
Unlock and access historical data on people associated with Medical Communication (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medical Communication (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medical Communication (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
